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Abstract: Microbial growth and biofilms formation are a continuous source of contamination on 
most surfaces with biological, inanimate, natural or man-made. The use of chemical surfactants 
in daily practice to control growth, presence or adhesion of microorganisms and ultimately the 
formation of biofilms and biofouling is therefore becoming essential. Synthetic surfactants are, 
however, not preferred or ideal and biologically derived surface active biosurfactants (BSs) molecules produced mainly by microorgan-
isms are therefore becoming attractive and sought by many industries.  The search for innovative and interesting BS molecules that have 
effective antimicrobial activities and to use as innovative alternatives to chemical surfactants with added antimicrobial value among 
many other advantages has been ongoing for some time. This review discusses the various roles of BS molecules in association with 
biofilm formation. Recent updates on several mechanisms involved in biofilm development and control are presented vide this article. 
Keywords: Antibacterial, antibiofilm, biosurfactants, bactericidal, disruption. 
1. BIOSURFACTANT: BROAD PROSPECTIVE MOLE-
CULES 
 A wide range of microbes’ produces unique metabolic mole-
cules namely biosurfactants (BS) that possess amphiphilic proper-
ties which reduces surface tension (SFT) and interfacial tension 
(IFT) of liquid media. BS molecules with lower critical micelle 
concentrations (CMC) and contact angle (CA) have many useful 
potential applications in a wide range of industries [1]. In addition, 
to all the above motioned features, rheological properties like vis-
coelasticity of BS has to be explored when considering employing 
BS compounds for various industrial application purposes. Viscoe-
lasticity represents the viscosity as well as elasticity property while 
undergoing deformation. When stress is applied, many naturally 
available substances display a shear flow and strain linearly. After 
removal of stress, the elastic materials rapidly regain their original 
state. However, BS shows a shear thinning performance therefore 
demonstrating a thixotropic behavior which is a typical characteris-
tic of a weak viscoelastic gel [2]. Like other soft materials micro-
bial biolm also exhibit viscoelastic characteristic which is a time-
dependent response to imposed automatic perturbation [3]. When-
ever there is an adsorption of one liquid into another medium, there 
is a remarkable change in the viscoelastic property of BS like other 
physical properties. Olofsson et al. [4] showed that different sur-
faces affect both the initial adhesion of organisms and the viscoe-
lastic properties of the interaction between the surfaces and adhered 
bacteria. Emulsification, wetting, foaming, properties of BS are 
very useful for commercial purposes. Characteristics like biode-
gradability, low-toxicity, production from cheap renewable raw 
materials and biocompatibility makes these types of compounds 
attractive towards various industrial applications. To date a huge 
number of high and low molecular weight BS with diverse  
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chemical nature has been reported produced by microorganisms. 
Fig. (1) represents few basic structure of well known BSs that has 
been reported in the literature frequently. Other important proper-
ties of BS including tolerance at wide ranges of pH, temperature 
and salinity is also one of the reasons for displaying preferences for 
BS use instead of synthetic, chemical surfactants by some industries 
[5, 6]. 
 BSs molecules have become an important area of interest for 
many researchers due to their effectiveness in various fields facili-
tated by their novelty and both structural and functional diversity. A 
remarkable property for many BSs is their varying antimicrobial 
activity e.g. the inhibition of colonization of pathogens on various 
surfaces. Two important properties such as bactericidal and bacte-
riostatic effects are significant to act as multi-target agents against a 
wide range of microorganisms [7]. Microbiologically sensitive 
surroundings need to be free from microorganisms. Bacteria grow-
ing in biofilm formation remain a significant challenge in biomedi-
cal field especially growing on abiotic material such as catheters 
and prosthesis, as they tend to be more tolerant/resistant towards 
antimicrobial treatments. Biofilms formation immediately starts in 
the body once a biomedical device has been planted within its 
niche. Frequent replacement of the implanted biomaterials from the 
body of a patient are often uncomfortable, costly, time consuming 
and may lead to damage of the cellular tissue. Biofilm development 
and infection can be limited by preventing microbial adhesion to 
the surfaces of medical devices [8-11].   
 Some of the important aspects of BS in relation to bacterial 
cells are highlighted in Fig. (2). It is important to note that a variety 
of BSs have been explored for their antibiofilm activity. Surfactants 
may affect the development of flagella, suggesting changes in the 
attachment capability of bacteria [12]. Bacteria also exhibit varied 
strategies to defend themselves from environmental attack and aid 
their own survival. Adhesion by bacteria to the surfaces results in 
energy saving and therefore, organisms try to shield themselves and 
protect their ecological niche. The main factors that play an impor-
tant role in the interference of bacterial adhesion are the initial bac-
terial hydrophobicity, the concentration and type of BS [13]. It is 
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common to note that the type of BS which may be active against a 
Gram-negative strain (like E. coli) may invariably be ineffective 
against the Gram-positive strain (example S. aureus) and vice a 
versa [14]. Antimicrobial action of BS molecules towards patho-
genic organisms has drawn much attention by many researchers 
[15]. A great change in bacterial surface hydrophobicity affected by 
BS molecule consequently varies the adhesion of organisms on 
solid surfaces. Therefore, such types of BS molecules are represen-
tative candidates towards the development of antibiofilm agents [1]. 
Intensive efforts are directed towards exploring new novel antimi-
crobial agents to combat increasing antibiotic resistance by bacteria 
and innovative approaches are essential to fight microbial infec-
tions. 
2. BIOFILM FORMATION BY VARIOUS MICROORGAN-
ISMS 
 Biofilms are complex aggregation of microorganisms that 
grows on various solid surfaces [16]. The concept of biofilms was 
first illustrated by Antonie van Leeuwenhoek but, the actual biofilm 
forming process was not revealed until much later. Several re-
searches have demonstrated the universal occurrence of biofilm 
forming microorganisms in different aquatic and industrial water 
bodies. An illustration of the overall process of biofilm formation 
process during bacterial colonization is shown in Fig. (3). Currently 
it is well documented that biofilms represent a heterogeneous struc-
tures of microbial cells imbedded into an exopolysaccharide (EPS) 
phase [17] and it is also suggested that the resistance demonstrated 
by antimicrobial agents is thoroughly related to the intrinsic three 
dimensional organizations of cells in this exopolymeric matrix. 
 Microbes can form colonies on biotic or abiotic surfaces which 
are represented as a single, small to large communities of multiple-
species. The formation of biofilm is one of the significant means for 
survival of microorganisms in their surrounding environment [18-
20]. Those microbes which form biofilm around them are compara-
tively more resistant to antimicrobial agents. When the microbes 
are in the planktonic form they are comparably less tolerant to these 
antibiotics. When organisms are in a planktonic form around us, a 
simple disinfection process could be sufficient for the removal of 
these attached microorganisms from biotic and abiotic surfaces. 
Generally, disinfection at regular interval is one of approaches used 
in many processes.  
 A lot of health related diseases occur due to the formation of 
biofilm by pathogenic microorganisms. The formation of biofilms 
in and on human body parts and, other food and health related ma-
terial can be a very serious issue. Various biomedical devices used 
during the care and treatment of patients needs to be free from op-
portunistic pathogens. Some of infections such as endocarditis and 
cystic fibrosis are directly associated with biofilms. With the devel-
opment of more advanced technologies, it is possible for us to un-
derstand the intra and inter-cellular processes of bacteria communi-
ties that oversee the overall bacterial physiological conditions. Sub-
sequently, cell to cell interactions results in formation of extracellu-
 
Fig. (1). The basic structures of four main types of low molecular weight glycolipids : (A- Dirhamnolipid; B-Trehalose monomycolates; C-Mannosylerythritol 
lipids; D-Lactonic Sophorolipid) and Two high molecular weight structure of cyclic lipopeptide (E- Emulsan; F- Surfactin).  
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lar complex polysaccharide based matrices resulting in the forma-
tion of biofilm structures [21].  To combat bacterial infections we 
therefore need to understand the mechanism of resistance develop-
ment and other aspects such as the molecular biology, biochemistry, 
physiology, nutritional requirement necessary for their growth and 
survival in their environments. There is an urgent requirement for 
novel antibiofilm compounds which can prevent the growth and 
accumulation of biofilm forming pathogenic microorganisms on the 
surfaces of various devices and host system. Initial biofilm forma-
tion process can be inhibited and ultimately one can get rid of dan-
gerous forms of biofilms. When surfaces are preconditioned with 
BS, the formation of biofilms can be prevented.  The use of chemi-
cal antimicrobial agents to control adhesion of microorganisms and 
ultimately the formation of biofilms has become routine practice. 
Due to the effect of surfactant molecules, cell membranes are dis-
rupted extensively leading to the lysis of cells, which increase the 
permeability causing leakage of cell metabolites. This ultimately 
alters the physical membrane structure and disturbs protein confir-
mation. Therefore, some of the important membrane functions like 
generation of energy and transport are severely affected [22]. 
 Bacillus subtilis is one of the most explored Gram-positive 
bacterium systems for genes, proteins, and molecular mechanisms 
responsible for formation of biofilms. D´az et al. [23] suggested 
that among Gram-positive bacteria species-specific molecular 
mechanisms are involved in biofilm formation. When Staphylococ-
cus epidermidis was reported it was thought of as a safe organism 
however quite some time ago this organism was identified as an 
opportunistic pathogen especially on prosthetic cardiac valves [24, 
25] and various orthopedic appliances [26]. Generally the S. epi-
dermidis does not produce slime; however, Christensen et al.  [27] 
showed that adherence of S. epidermidis to medical devices is me-
diated through the production of slime and at the same time it is 
also the main factor responsible for its infections. In biofilm com-
munities where multi-species are involved, a number of complex 
reactions take place which influence its’ overall characteristics. 
Studies on multispecies interactions in biofilm environment how-
ever, remain mostly superficial [28]. A very limited efficacy of 
existing antibiofilm solutions (based on planktonic bacterial physi-
ology) is reported; therefore we need to explore more suitable alter-
natives to conventional therapies [29].  
 To some extent, studies including the interactions and resources 
used by bacteria to flourish in complex biofilm communities have 
encouraged researchers to propose alternatives to conventional 
antibiotics used against pathogens [30]. There is some supporting 
evidence from Qin et al. [31] relating the disruption of staphylococ-
cal biofilms through the bactericidal effects. When an organism 
 
Fig. (2). Importance of biosurfactant molecule for bacterial cell.  
 
 
Fig. (3). The overall mechanisms of formation of biofilm by microorganisms.  
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community is considered, several bacterial species often coexist and 
contend for resources available in the surrounding environment. 
Pseudomonas aeruginosa the opportunistic pathogen make use of 
extracellular products for their interaction with the nosocomial 
biofilm forming pathogen namely S. epidermidis. Qin and collabo-
rators [31] suggested that the quorum-sensing-controlled factors 
from P. aeruginosa supernatant (polysaccharides) inhibit the 
growth of S. epidermidis in planktonic as well as biofilm forms. P. 
aeruginosa extracellular products are important as microbial com-
petition factors that overcome competition with S. epidermidis. 
Such observations may provide clues for the development of a 
novel strategy for controlling S. epidermidis biofilms. 
3. MICROBIAL BIOSURFACTANT AS ANTIBIOFILM 
AGENTS 
 There is a range of properties shared by BS molecule that may 
affect their interactions and association with biofilms. Some of the 
different roles conferred by BS molecule that may interfere with 
biofilm formation by microorganisms are represented diagrammati-
cally in Fig. (4). 
3.1. Alteration of Cell Surface Properties  
 Traditionally bacterial population is divided into the two main 
groups of Gram positive and Gram-negative which are based on 
cell-envelope organization. Gram negative bacterial outer mem-
brane which is composed of lipopolysaccharides (LPS), lipopro-
teins and phospholipids where hydrophobic interactions are in-
volved in linking the peptidoglycan layer [32]. Number of porins 
and efux pump are also embedded in the LPS layer [33]. Makin 
and Beveridge, [34] suggested that the quantity and type of LPS 
shows a profound effect on the interactions of the microbial cell 
with its environment. Denyer and Maillard, [35] reported the pres-
ence of four major outer membrane proteins (OMPs) including 
(OprF, OprP, OprB, OprD) and two minor (OprC, OprE) in the 
membrane of P. aeruginosa.  Several chemical agents, permeabiliz-
ing agents modifies the outer membrane of Gram-negative bacteria 
resulting the changes in surface properties and membrane perme-
ability and hydrophobicity.  Alterations in the membrane due to 
change in the composition of membrane fatty acids are considered 
to be one of the most imperative adaptive mechanisms in bacteria 
[36]. 
 Rhamnolipid (RHL) BS potentials for industrial and environ-
mental applications is the subject of many literature reports. Few 
researchers however have discussed its interaction of and effects on 
bacterial surfaces and membrane active properties [37-39].  Such 
changes in the lipid and fatty acid composition of the bacterial cell 
membrane are due to effect of interaction with BS have been re-
ported [40]. Sotirova et al. [40] worked towards usage of antimi-
crobial properties of methyl (MTS) and ethyl (ETS) esters of thio-
sulfonic acid alone and in combination with RHL-BS for their abil-
ity in disrupting the normal physiological functions of pathogenic 
microorganisms’ viz., P. aeruginosa, B. subtilis, Alcaligenes fae-
calis, and Rhizopus ngtricans. Sotirova et al. [40] reported the 
combination of RHL with thiosulfonic esters has a synergistic effect 
towards decreasing the bactericidal and fungicidal concentrations of 
MTS and ETS. The same group of researchers [41] has previously 
reported the interaction of RHL-BS with bacterial cells affecting the 
change in outer membrane proteins of P. aeruginosa. RHL-BS 
obtained from Pseudomonas sp. PS-17 has been used to demon-
strate the effect on the cell surface structures of Pseudomonas 
aeruginosa NBIMCC 1390. Note worthy observation was put for-
ward by these researchers stating that concentrations of RHLs be-
low and above CMC can provoke a multi-component response of 
the bacterial cells without any influence on growth and viability. 
Concentration above CMC value reduces total cellular LPS content 
of 22% subsequently increasing the cell hydrophobicity to 31% 
adherence. However, at concentration below CMC value the LPS 
components of the bacterial outer membrane are not affected in-
stead change in OMP compositions were observed. It was con-
cluded that BS can affect the cell surface morphology drastically 
which is totally dependent on concentration. The release of LPS 
from the cell surface may be due to solubilization of the outer 
 
Fig. (4).  Different roles of biosurfactant molecule for interference of  biofilm formation  by microorganisms.  
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membrane by binding of aggregated BS to the membrane followed 
by removal of the LPS component. This has been supported by 
authors from the evidence revealed from analysis of the OMP pro-
files disclosing the decrease in the amount of major proteins like 
Opr F, Opr D, Opr J and Opr M. 
 Quite a few surface active molecules, (chemically/biologically 
originated) alter the cell surface properties [42] which are reflected 
from the following examples. Purified RHL-BS affect the hydro-
phobicity of octadecane-degrading cell and the differences in rates 
of octadecane biodegradation was analysed. Rhamnolipids in-
creases the cell hydrophobicity of the slow degraders where as hy-
drophobicity of the fast degraders was unaffected. Of course the 
change in the hydrophobicity was dependent on the concentration 
of RHL [43]. Rhamnolipid molecule induces the removal of LPS 
from Pseudomonas aeruginosa and ultimately affects the bacterial 
cell surface properties and interaction with hydrophobic substrates 
through the enhancement of cell surface hydrophobicity. On similar 
lines, Al-Tahhan et al. [44] observation supported that the loss of 
LPS in P. aeruginosa strains after treating with RHL (low concen-
trations) resulting increase in the cell surface hydrophobicity. Lim-
ited information was available on the interaction of biologically 
originated surface active molecules with bacterial cells. Kaczorek et 
al. [45] observed the different way of surfactant in modification of 
cell surface properties. Surface properties of Stenotrophomonas 
maltophilia were investigated to determine the influence of hydro-
carbons and surfactants on surface and enzymatic characteristics. 
There is much change in the fatty acids profiles which thereby fa-
cilitated the adherence of cells to hydrophobic compounds. RHLs 
BS increases the cell permeability and inhibit the activity of the 
bacterial cells due to the efflux of intracellular protein, ions and 
other intra-cellular components, which ultimately lead to the cell 
death. Such properties allow the use of BS as an additive in antibi-
otic formulations and other antimicrobial compounds in order to 
enhance the effectiveness of chemotherapeutic agents [46]. 
3.2. Reduction in Adherence Abilities to Surfaces, Prevention of 
Bacterial Colonization 
 Surfactin and RHL, both BS types are able to prevent attach-
ment of biofilm formed by various pathogens [47]. BS produced by 
Bacillus species inhibits adhesion of biofilms probably through 
binding to the cell surface or its components and therefore altering 
the hydrophobicity of the outer membrane [48, 49]. Such effect 
would promote dispersal of preformed biofilm as reported by Mire-
les et al. [47] using surfactin on Salmonella enterica which inhib-
ited adhesion to polyvinyl chloride (PVC) without inhibiting the 
growth. Rivardo et al. [14] also reported anti-adhesion activity 
against biofilms by lipopeptide BS produced by B. subtilis and B. 
licheniformis.  The two lipopeptide type BS inhibited adhesion of 
biofilm of pathogens selectively against Gram –ve E.coli CFT073 
and Gram +ve S. aureus ATCC 29213 with decrease of 97% and 
90%, respectively. Cyclic lipopeptide BS isolated from Bacillus 
amyloliquefaciens AR2 inhibits C. albicans biolm by altering the 
cell surface hydrophobicity or hampers germ tube formation. There 
is also a reduction of the mRNA expression of hyphae specific 
genes – HWP1 and ASL3.  About 46–100% of the biolm forma-
tion is inhibited by tested BS. Interesting report from Dusane et al. 
[50] documented that RHLs molecules exhibit biofilm disruption 
activity of biofilms formed by ascomycetous dimorphic fungus viz., 
Yarrowia lipolytica.  
 Harshey et al. [51] reported a cyclic lipopeptides (surfactin) 
obtained from B. subtilis with the capacity to inhibit biofilm forma-
tion by coating medical and industrial objects. Surfactin is very 
stable at higher temperature treatment retaining biofilm inhibiting 
properties after storing surfactin-baked catheters (One hour at 
60°C) or for 5 days at room temperature. There are number of re-
ports for surfactin molecules eradicating the adhesion of biofilm 
producers.  There are difference in the activity depending upon the 
producing strain and the concentration of BS compound. Some of 
the reports available in literature have also tested the properties of 
mixture of surfactin compound with other compound such as fen-
gycin (1: 1) against planktonic E. coli [52]. Work by Mireles et al. 
[47] indicated that there was complete extermination of Salmonella 
enteric and E. coli, biofilm adhesion on urinary catheters surface 
pre-coated with 5 g/ml of surfactin whereas absolutely no effect 
was detected against P. aeruginosa. 
 Similar to Bacillus strains, variety of Pseudomonas species has 
been extensively explored for BS possessing antiadhesive activities. 
Work demonstrated by Rodrigues et al. [9] suggest that RHLs ob-
tained from P. aeruginosa DS10-129 hold down bacterial adhesion 
of S. epidermidis, Streptococcus salivarius isolated from explanted 
voice prostheses to silicone rubber. Hence these RHLs have poten-
tial for the development of bio-detergent solution for cleansing 
purpose of prostheses. Therefore it can prolong the lifetime of this 
material which would be useful to the laryngectomized patients. 
Coating of polytetrafluoroethylene (PTFE) surface with RHLs BS 
has ability to reduce Listeria monocytogenes attachment [53]. D´az 
et al. [23] recently reported that sophorolipids type BS containing 
acid/lactonic content are efficient bactericidal agent which can 
bring out the cell death of planktonic cells of some Gram positive 
and Gram negative bacteria. This research group had compared the 
antimicrobial activity of sophorolipid BS with conventional antimi-
crobial compounds having bacteriostatic effects. Sophorolipids also 
disrupts biofilms at concentration is > 5% (v/v). Thus, authors con-
cluded that sophorolipids molecules are promising bactericidal 
agents biomedical application point of view due to their antimicro-
bial properties, and potential use to prevent adhesion and biofilm 
disruption.  
 One of the best explored probiotic strains for BS production is 
Lactobacilli species. Velraeds et al. [54] studied 15 Lactobacilli 
strains and showed that the isolates produce BS in the mid-
exponential and stationary growth phases. Inhibition of initial adhe-
sion (99%) of uropathogenic strains like Enterococcus faecalis 
1131 on glass surface in a parallel-plate ow chamber was success-
fully demonstrated by the BS from few lactobacilli strains. Subse-
quently Velraeds et al. [55] reported on surlactin, a BS from Lacto-
bacillus sp. which decreased the initial adhesion of E. faecalis 1131 
on a hydrophilic and a hydrophobic substratum in a parallel-plate 
flow chamber system. They carried out studies by using phosphate-
buffered saline and pooled human urine as a suspending fluid. Such 
studies were highly significant for the development of antiadhesive 
biologic coatings for catheter materials. It is important to note that 
the efficiency of BS’s under investigation are often affected by the 
hydrophobicity of the substrate, the suspending fluid, and uropa-
thogen present in the system. Velraeds et al. [56] has contributed 
towards utilization of surlactin' from L. acidophilus RC14 BS to 
inhibit the initial adhesion of various uropathogenic bacteria on 
medical devices like silicone rubber using parallel-plate flow 
chamber in filter-sterilised pooled human urine. Other piece of 
work contributed by the same research group [57] confirmed that 
adhesion and growth of naturally occurring uropathogens from 
human urine is discouraged by BS produced from Lactobacilli 
strains. It should be kept in mind that efficiency and variations in 
this type of activity is dependent on strains of Lactobacilli present 
in human system and for few BS, it is also affected/related to sex.  
Therefore, clinically it is very important to reduce bacterial adhe-
sion and wipe out the biofilm population for removal of bacterial 
colonization from biomedical devices surfaces used in urinary tract 
infections.  
 Sambanthamoorthy et al. [58] evaluated antimicrobial, anti-
adhesive and anti-biofilm abilities of cell bound BS produced by 
two strains L. jensenii and L. rhamnosus against clinical Multidrug 
Resistant (MDR) strains of Acinetobacter baumannii, Escherichia 
coli, and S. aureus. The cell associated BS bears anti-adhesive and 
anti-biofilm abilities against A. baumannii, E. coli and S. aureus 
and showed that BS can be used as an alternative therapeutic ap-
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proach for the prevention and/or treatment of hospital-acquired 
infections. L. acidophilus produces BS which has ability to inhibit 
biofilm formed by S. aureus and S. epidermidis. Today several 
techniques like, confocal laser scanning microscopy and image 
PHLIP analysis are routinely used for evaluation of bacterial initial 
adhesion and biofilm formation. Their report also suggests that all 
different activities are dependent on strain as well as dose or con-
centration. The dispersion or disruption of biofilm morphology can 
be hastened by addition of BS. This contribution by Walencka et al. 
[59] highlighted the use of L. acidophilus-derived surfactants in 
inhibiting bacterial deposition rate and biofilm development, their 
maturation. This activity is believed to be achieved due to the influ-
ence on the cell-surface hydrophobicity of staphylococci without 
affecting their growth. 
 Much reliable approach to prolong the lifespan of voice pros-
theses is available from the work on BS produced by Lactococcus 
lactis and Streptococcus thermophilus that reduces the microbial 
numbers on prostheses [60]. BS produced by Lactobacillus sp. 
CV8LAC inhibited the adhesion of two C. albicans pathogenic 
biofilm producer strains (CA-2894 and DSMZ 11225 planktonic 
cell [61]. The authors observed that the planktonic cells of C. albi-
cans are not inhibited and therefore they concluded that the com-
pound has anti-biofilm potential rather than antimicrobial activity. 
Pradhan et al. [62] reported a Lysinibacillus fusiformis S9 for gly-
colipid type BS production and explored its inhibition of biofilm 
formation potential against E. coli and S. mutans. Authors had an 
interesting observation that that the concentration of 40 g ml-1 the 
BS does not show any bactericidal activity but constrain the forma-
tion of biofilm entirely. This was the first report available on L. 
fusiformis ability to produce glycolipid type of BS capable of inhib-
iting biofilms of pathogenic bacteria on hydrophilic (glass) as well 
as hydrophobic (catheter tubing) surfaces. In this way we can pre-
vent biofouling of biomedical surfaces without any toxicity to bio-
logical system.  
 An interesting contribution by Kanmani and collaborators, [63] 
investigating EPS production from marine S. phocae PI80; they 
examined the chemical nature, antibiolm, antioxidant activity and 
functional properties of EPS and reported excellent emulsifying and 
occulating activity which are much similar to xanthan gum, gela-
tin and guar gum. EPS was also suitable for inhibiting biolm for-
mation and therefore could be used as food grade adjunct. Kiran et 
al. [64] investigated the antibiofilm activity of a glycolipid BS iso-
lated from the marine Brevibacterium casei MSA19 against patho-
genic biofilms. The BS has a broad spectrum of antimicrobial activ-
ity and proved to be bacteriostatic and disrupts biofilm formation 
under dynamic conditions, which was consistent against mixed 
pathogenic biofilm forming bacteria. Glycolipid type BS produced 
by a tropical marine strain of S. marcescens displayed several ac-
tivities like antimicrobial, anti-adhesive and biolm disruption 
against selected pathogenic and marine biofouling microorganisms 
[65]. Such glycolipid BS therefore is useful materials for develop-
ment of novel antibiofilm agents. 
3.3. Recent Advances of Nanoscale Approaches Towards Re-
duction in Colonization of Pathogens  
 Nanotechnology-Nanoscience based recent approaches are at-
tracting researches around the globe interested in controlling 
biofilms in medical and healthcare applications. Nanoscale materi-
als are providing alternative solutions towards inhibition of biofilms 
on living and non living surfaces. Researchers are aware with the 
different microbial behavior in planktonic and during biofilm for-
mation. This knowledge has been found to be essential to tackle the 
biofilm formation by pathogens in smarter ways. Several efforts 
have been taken continuously for developing novel mechanisms to 
eliminate microbial biofilm from medical devices.  
 In this regard, Singh et al. [66] studied the quantitative charac-
terization of the influence nanostructured surfaces on bacterial ad-
hesion and biofilm formation. Using supersonic cluster beam depo-
sition, they produced nanostructured titania thin films with con-
trolled and reproducible nanoscale morphology and characterized 
the adhesions of Escherichia coli and Staphylococcus aureus on 
nanostructured titania surfaces. They observed that the increase of 
surface roughness improves protein adsorption, which in turn 
downplays bacterial adhesion and biofilm formation. As roughness 
increases up to about 20 nm, bacterial adhesion and biofilm forma-
tion are enhanced; the further increase of roughness causes a sig-
nificant decrease of bacterial adhesion and inhibits biofilm forma-
tion. They interpret the observed trend in bacterial adhesion as the 
combined effect of passivation and flattening effects induced by 
morphology-dependent protein adsorption. The same group further 
showed that S. aureus and E. coli interaction with nanostructured 
surfaces shows an increase in adhesion and biofilm formation with 
increasing nanoscale morphological properties [67]. 
 Learning lessons from efficient natural processes to design 
smart fabrics, mimicking natural phenomena also were reviewed for 
the synthesis of nanoparticles for antimicrobial purposes. Singh et 
al. reviewed nature’s design and subsequent parallel advances in 
biomimetic materials and polymer sciences, with combining inter-
disciplinary engineering principles to mimic nature inspired designs 
of nanostructures materials into fabrics in textile industries to com-
bat microbial infections [68]. The same group [69] further emphasis 
on the systematic evaluation of nanomaterial toxicity in primary 
cells derived from vital organs and the need to develop an interna-
tional consortium for a materialomics database was encouraged.  
 Not only has the design of smart nanostructures, nanoparticles 
also showed interesting applications for inhibiting the growth of 
microorganisms and biofilm. Silver nanoparticles were shown to 
affect the microbial cell at many different levels viz., bacterial wall 
integrity, synthesis of proteins and DNA through slow release of 
Ag+ ions [70] leading to effective contact with and elimination of 
microorganisms and biofilms [71-74]. Usage of metallic NPs offers 
better opportunities to avert adhesion of pathogens and subse-
quently formation of biofilm.  Bacterial biofilms on catheters 
formed by E. coli, S. aureus, P. aeruginosa, S. epidermidis, C. albi-
cans has been controlled using NPs of silica containing nitric oxide 
[75,76]. Rai and coworkers [77] also controlled biofilm formation 
with the help of silver NPSs.  
 It is also reported in literature that TiO2 and EDTA nanoparti-
cles can affect biofilms formed by Candida albicans. Haghighi et 
al. [78] proposed to use coating of TiO2 nanoparticle on medical 
devices in order to treat and or prevent the fungal biofilms. Differ-
ent NPSs formulations have been used as antimicrobial sprays es-
pecially silicon compounds and organic quaternary ammonium 
salts.  He et al. [79] synthesized NPs having different charged sur-
faces so that during ionic physical interaction they bind to microbial 
cells and subsequently remove them from the surfaces. This ionic 
interaction approach has proved to be able to inhibit as well as 
elimination of biolm forming organisms. Few years’ back the use 
of superparamagnetic iron oxide (-Fe2O3) NPs was employed ef-
fectively to treat biolm [80]. Taylor and Webster [80] put forward 
their observation that the generated hydroxyl radicals depolymerize 
the polysaccharides, leads breakage in DNA and ultimately results 
in the inactivation of enzymes which are an important component 
for the EPS matrix. The superparamagnetic iron oxide possesses 
tremendous potential for leakage of cell membranes of planktonic 
cells. 
 Our research group Gholap et al. [81] developed an antibiofilm 
NPS agent with an ability to inhibit quorum sensing mediated 
biofilm formation in pathogenic organisms. The prepared a nano-
composite, CdTe–TiO2 has been proved as effective impeder of 
bacterial growth and biofilm formation (Fig. 5). About 57% biofilm 
growth is inhibited with this nanocomposite and therefore can be 
used as antibacterial agent against Gram positive and Gram nega-
tive organisms. This antibacterial activity of nanocoposite on bacte-
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ria is due to the generation of reactive oxygen species inside the 
cells leading them to its rupture. Therefore, TiO2 or CdTe sensitized 
TiO2 has great potential as an antibiofilm agent and has promising 
applications in photocatalytic destruction. The same research group 
Patil et al. [82] synthesized quantum dots conjugated zinc oxide 
nanostructures (ZnO/CdTe) an anti-biofilm agent. The nanocompo-
site impedes biofilms due to photocatalytical action on the cell 
biofilm surfaces (Fig. 6). The use of hydrothermal method for 
ZnO/CdTe nano-structures array synthesis are advantageous since 
working at low growth temperature and usage of inexpensive mate-
rial used in fabrication. While using NPs in treatment of microbial 
biofilm, certain concepts needs to be considered; foremost is the 
long term release of the active agent, the increased solubility and 
bioavailability of the agent with reduction in aggregation and fi-
nally improving its effectiveness [83]. It is very important that in 
addition to the conventional approaches, novel concepts are adopted 
to fight against biofilms and towards increasing the high quality of 
food safeties and health [84]. 
3.4. Altering the Physical Membrane Structure and Increase in 
Membrane Permeability Leading to Metabolite Leakage  
 Banat et al. [1] has put forward a hypothesis that BS molecules 
play a leading role towards development and maintaining biofilms, 
may be partly through the maintenance of water channels through 
the biofilm. This involves the enhanced movement of nutrient and 
exchange of gases which ultimately results in the dissociation of 
parts of the biofilm into planktonic mobile forms.  Surfactin a cy-
clic lipopeptide based antibiotic disturbs the integrity of the cyto-
plasmic membrane’s phospholipid composition and its physical 
properties by three different ways [85]. These include interacting 
with lipid membrane as (a) Mobile cation carrier [86, 87] (b) For-
mation of cationic channels [88, 89] (c) Destruction of membrane 
through the detergent effect [90]. Lipopeptide type BS molecules 
form selective cationic channels in lipid bilayer membranes and 
thus are involved in the functional channel-formation of target cells 
[91, 92].  
 The main reason for antimicrobial effect of the BS are believed 
to be due to their adhering property to the cell surfaces leading to 
weakening in the integrity of cell membrane and therefore disrup-
tion in the nutrition cycle [93]. Another reason is due to the struc-
ture of BSs, where among polar and non polar portion of the mole-
cules, the fatty acids moiety of BS get inserted into the cell mem-
brane causing an increase in the size of the cell membrane and con-
siderable changes in the cells.  Depending upon the type of BS, 
membrane integrity is affected in different ways. It may happen that 
 
Fig. (5). SEM and CLSM images of the biofilm (Pseudomonas aeruginosa) and its inhibition in presence of CdTe–TiO2 nanocomposites  - Adopted from 
Gholap et al. 2013 [81]. 
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the shorter acyl tails get inserted into the cell membrane disturbing 
the cytoskeletal elements and the plasma membrane. Such dislodges 
the membrane away from the cytoplasmic contents [94]. Other 
methods of actions for membrane disruptions by lipopeptide type 
BS may be through accumulating intra membranous particles in the 
cells increasing electrical conductance of the membrane Thimon et 
al. [95]. In contrast, Carrillo et al. [96] suggested that the lipopep-
tide BS increases the permeability of membrane though the interac-
tion with the cell membrane phospholipids 
3.5. Interference of Protein Conformation, Important Mem-
brane Functions  
 At lower CMC values, the potential gentle action of BS on non 
growing cells and neutral effect on the growth of microbial strains 
offer several applications in environmental bioremediation as well 
as biomedicine fields. BS affects the permeability of bacterial cells 
which is obviously dependant on its concentration. This effect is 
demonstrated by Sotirova et al. [97] on Gram negative cells such as 
P. aeruginosa, E. coli, and Gram positive B. subtilis in vivo and in 
vitro conditions. BS has neutral or detrimental effect on the growth 
of Gram-positive strains. When media supplemented with BS it 
does not affect the growth of Gram-negative.  The BS shows higher 
permeability with B. subtilis (a Gram positive bacterium) as com-
pared with Pseudomonas aeruginosa (a Gram negative bacterium). 
Scanning-electron microscopy analysis indicates that the BS PS 
does not exhibit disruptive action on resting cells however it is det-
rimental on growing cells of B. subtilis. Ortiz et al. [98] investi-
gated the molecular interaction of trehalose based glycolipid BSs 
isolated from Rhodococcus sp. on the membranes composed of 
phosphatidylethanolamines of different acyl chain length and satu-
ration. The BS under studies has capacity to get incorporated into 
phosphatidylethanolamine bilayers and affect all structural proper-
ties. Authors had proved this using different techniques like differ-
ential scanning calorimetry (DSC), small and wide angle X-ray 
diffraction and infrared spectroscopy (IR). Trehalose lipid molecule 
intercalates between the phospholipids ones, and can disturb the 
phospholipid palisade. It is also important to note that BS does not 
affect the macroscopic bilayer organization of saturated phosphati-
dylethanolamines. There is a good miscibility between trehalose 
lipid and saturated phosphatidylethanolamines. BS also increases 
the hydrocarbon chain conformational disorder and also has a sig-
nificant dehydrating effect of the interfacial region of the saturated 
phosphatidylethanolamines. 
 Ortiz et al. [99] also carried out studies on bacterial trehalose 
lipid of Rhodococcus sp. to observe its interaction with dimyris-
toylphosphatidylserine membranes using same techniques. Treha-
lose lipid enhances the fluidity of the phosphatidylserine acyl 
chains and changes the local environment of the polar head group. 
There is also a decrease in the hydration of the interfacial region of 
the bilayer. The BS also makes it possible to affect the thermotropic 
transition of dimyristoylphosphatidyserine in the presence of cal-
cium. The authors proposed that the BS is incorporated into the 
phosphatidylserine bilayers and produces structural perturbation 
that may affect the functional properties of the membrane. Other 
techniques like Fourier transform infra red spectroscopy and fluo-
rescence polarization has been utilized to observe the effect of bac-
terial di-RHL on phospholipid membranes composed of 1, 2-
Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC).  Sánchez et al. 
[100] showed that the BS alters both the acyl chain and the interfa-
cial region of the bilayer. Such type of molecules has great applica-
tions for making their membrane more hydrophobic in nature and, 
thereby becoming more susceptible to hydrophobic antibiotics.  
 Other interesting properties of a succinoyl trehalose lipid iso-
lated from Rhodococcus sp. has shown its ability to have a great 
tendency of partitioning into phospholipid membranes [101]. 
Zaragoza et al. [101] used human red blood cells (RBC) as an ex-
perimental model. Trehalose lipid causes the swelling of erythro-
cytes followed by hemolysis at concentrations well below its criti-
cal micellar concentration. In presence of trehalose lipid, K+ release 
precedes that of hemoglobin. Osmotic protectants of the appropriate 
size added to the external medium make it possible to avoid hemo-
lysis. Trehalose lipid lyse the human erythrocytes by the colloid-
osmotic mechanism possibly through the formation of enhanced 
permeability domains, or “pores” enriched in the BS within the 
erythrocyte membrane. Most of the concepts are apparent through 
the scanning electron microscopy indicating that trehalose lipid-
induce spherocytosis and echinocytosis of RBC.  
 
Fig. (6). SEM and CLSM images of the biofilm (Pseudomonas aeruginosa) and its inhibition in presence of ZnO and ZnO/CdTe nanostructure - Adopted from 
Patil et al, 2015 [82]. 
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 Other glycolipid namely di-RHL from the crude RHL BS in-
duces leakage in cellular internal contents, which was evident by 
the carboxyuorescein, in phosphatidylcholine unilamellar vesicles 
at a concentration lesser than its CMC [102]. Lysophosphatidylcho-
line, the cone-shaped lipids in the membrane, accelerates leakage, 
other lipids like phosphatidylethanolamine, decreases the leakage 
rate. When cholesterol concentration is high it protects the mem-
brane against di-RHL-induced leakage. Di-RHL can also cause 
hemolysis of human erythrocytes through a lytic mechanism. In 
addition to these effects, BS also alters the usual disc shape of 
erythrocytes into that of spheroechinocytes which was observed 
through scanning electron microscopy [102].  
3.6. Quorum Sensing (QS) 
 Quorum sensing is a system of stimulate and response corre-
lated to population density. Different groups of organisms use the 
mechanisms of quorum sensing for coordination purpose. 
 Expression of gene is controlled according to the density of their 
population present at that time in their environment. Various activi-
ties including development of biofilm formation, bioluminescence 
production, antibiotic resistance, sporulation, plasmid conjugal 
transfer, virulence, antibiotic synthesis and secretion of enzyme are 
well coordinated through cell-to-cell communication commonly 
known as QS. The phenomenon of QS may take place within a 
single species of bacteria and even among diverse species. It is also 
possible to control different processes in host system. In simple 
ways we can say that QS served a simple indicator of population 
density or the cell's dispersion rate into the immediate environment. 
The development of biofilms and QS are closely interconnected 
mechanisms. During the formation of biofilms a cooperative group 
behavior of bacteria is involved. The bacterial population becomes 
embedded in a self-produced complex extracellular matrix. QS 
mainly activates the dispersion process of biofilm [103]. Generally 
low molecular weight molecules like acyl homoserine lactones 
(AHLs), furanosyl borate diesters (AI2), cis-unsaturated fatty acids 
(DSF family signals) and peptides are considered to be the QS 
molecules.  
3.7. Biofilm Detachment  
 The life cycle of biofilm includes certain phases (i) Initial adhe-
sion, (ii) microcolony formation, (iii) Maturation of biofilms (iv) 
finally detachment (Fig. 2).  Bacteria need active mechanisms to 
leave biolm and return back to the planktonic (free-living) state. 
This fourth phase has not been focuses and explained much in the 
literature. Detachment of biofilm process is also a regulated ener-
getic one where certain proteins, genes are expressed. Boles et al.  
[104] put forward that variants of discovered P. aeruginosa display 
accelerated detachment of biolm. There is a spontaneous raise of 
hyper-detaching variants from biofilm at a high frequency, and 
leads vigorous detachment under unusual biolm growth condi-
tions. Further Boles et al. [105] showed that the detachment 
mechanism of variants requires the BS RHLs. This has been ob-
served in case of wild type strains of Pseudomonas species. Under 
this condition there is rapid restoration of antibiotic sensitivity to 
separating bacteria. RHLs attack directly on the biolm matrix and 
disrupt the components, possibly incorporating the matrix into mi-
celles. RHLs may disrupt cell surface structures which assist 
biofilms in adhesion process.  
 Al-Tahhan et al. [44] has shown that RHLs play a role in re-
leasing lipopolysaccharide from P. aeruginosa. Other surface ap-
pendages may face the same situation. The overall cumulative ef-
fect on biofilm and matrix persuade disruption and finally cell de-
tachment. Comparable work from Davey et al. [106] suggested the 
working of similar mechanism in maintaining the uid channels 
that surround biolm structures. Conversely here, RHLs may act on 
cell–surface rather than cell–cell or cell–matrix interactions.  Is has 
been suggested by Davey et al. [106] and Klausen et al. [107, 108] 
that in case of P. aeruginosa surface-associated motility and BS 
production both play crucial role structural development of 
biofilms. Two separate groups of researchers [106, 109] reported 
similar observation of mutants of P. aeruginosa rhlA forms colony 
on a flat biofilm. However both of Pang et al. [110] disagree with 
the opinion of Davey et al. [106] who documented that BS mole-
cules are essential in the initial phase of microcolonies formation, 
nevertheless contributes towards maintenance of the channels be-
tween the microcolonies once they are formed. The RHLs molecule 
promotes swarming motility and alters cell surface charge which 
mediates detachment of biofilm. In short we can claim that RHLs 
are the compounds that can act against broad spectrum of microbes 
[47]. Using this approach it is easy therefore very much possible to 
disrupt the established biofilms. Due to the action of RHLs, several 
cavities are formed within the centre of biolm structures. In case 
of variants, central hollowing pattern that is also observed in aged 
wild-type biolms. Similarly biolm interior detachment has been 
observed for S. aureus [111] and in the oral pathogen like Actino-
bacillus actinomycetemcomitans where detachment is mediated by 
the enzymatic action of n-acetylglucosaminidase instead of surfac-
tant [112]. This indicates that the central hollowing detachment 
pattern possibly is common across species, in spite of having work-
ing the different operative detachment mechanisms. 
4. METHODS INVOLVED IN INVESTIGATING THE 
BIOFILM FORMED BY MICROORGANISMS  
 Differences between planktonic and biofilms cell behavior, 
characteristics and general states within microbial culture are well 
known and reported in literature. Planktonic (free living cells) be-
havior of diverse populations of cells has also been studied. There-
fore, different methodologies are used in order to analyze their in-
teractions with antimicrobial agents. One typical laboratory method 
may not be suitable for use to study all types of biofilms.  Initially 
biofilm assays were very analogous to the experimental set up for 
planktonic cells. The output of this work tried to represent BS as 
weak compounds in comparison with conventional antimicrobial 
agents. Soon after, as research progressed it became apparent obvi-
ous that these tests were not reflecting the efficacy of BS accu-
rately. Currently experiment set up in situ conditions offer a more 
representative picture [1]. Various methods suitable for evaluating 
BSs effects on biofilm disruption along with their advantages and 
limitations are listed in Table 1. Most of the methods pre-coat the 
surface with a known amount of BS overlaid with microbial biofilm 
[113]. Several methods are currently being used by researchers in 
order to quantify the growth of bacteria in the presence or absence 
of various antimicrobial compounds.  
4.1. Microtiter Plate Static Biolm Model 
 This was the first method specially developed for quantification 
of biofilm. The attachment of microbes to abiotic surfaces is quanti-
fied with the help of this assay. For the first time Christensen et al.  
[114] studied the attachment of Staphylococcus aureus a coagulase-
negative bacterium to the plastic surface. Since then it has been 
used regularly to study many other species. Short incubation period 
(1–2 h), longer incubation period (20 h) assists the analysis of 
initial attachment of bacteria to surfaces and biofilm formation 
respectively. It is a high-throughput technique for understanding the 
different parameters however less well suitable for biofilms pos-
sessing antimicrobial resistance properties. It is a challenging task 
to visualize the biofilms microscopically since live cells and matrix 
material both are stained by the dye. Several authors have utilized 
this assay in different ways and observed some kind of interaction 
of BS molecules with the microorganisms within the biofilm. Some 
contributions on this aspect are summarized in Table 2. 
4.2. Tube Assay 
 This technique was developed by modification of the standard 
method of Christensen et al. [114] to test biofilm production. In  
 
1438    Current Pharmaceutical Design, 2016, Vol. 22, No. 11 Satpute et al. 
Table 1. Summary for different methods used for studying biofilm formed by the microorganisms. 
Name of the Method  Quantitative/Qualitative Advantage Limitations 
Crystal violet (CV) assay Quantitative This method is very inexpensive and accurate results can be 
obtained by conducting the experiment for several times.  
Low reproducibility. Staining of living, dead and 
biofilm matrix by CV does not provide any informa-
tion on the actual number of living bacteria and 
therefore cannot evaluate the anti-biofilm efficacy of 
antimicrobial agents. 
Microtiter plate static 
biolm model or 
Tissue culture plate 
method (TCP) 
 
Quantitative It measures rapidly the relative biomass levels. High-
throughput, screening for mutants defective in attachment 
or evaluation of the effects of different treatments on at-
tachment or biolm formation. Well discrimination between 
weak and biofilm negative isolates. 
Less suitable for studies of biolm structure, antimi-
crobial resistance properties. 
Flow cell system Qualitative Formation of biolm at the biologically relevant surfaces 
like host–pathogen inters actions. Therefore, biologically 
relevant mimic of the in vivo situation. 
It has limited experimental throughput due to diffi-
culty in collecting biomass of biofilm. 
Bioluminescent assay Quantitative  It is rapid, simple, time saving, more convenient than the 
microscopic technique and suitable for automation. Bacte-
rial attachment on different irregular surfaces can be stud-
ied. Live bacteria- metabolic activity depending on their 
ATP molecules are detected. 
Unable to detect the adherence accurately. 
Tube biolm reactors Quantitative Accumulated mass of large biofilms can be collected by 
scraping from the tubing. 
High-throughput analysis cannot be done. 
Rotating disk reactors 
(RDR)  
 Shear strength formed by the freshwater communities of 
bacteria on biofilms formation can be analysed. 
Concentric cylinder 
reactors (CCR) 
Quantitative Accommodates large numbers of coupons or chips and 
allows dose–response killing relationships accurately  
determined from a single biofilm. 
Analysis of only one strain or mutant at a time per 
reactor. More number of strains is not possible with 
this system. Difficulty in sample taking; temperature 
control conditions are dependent on external devices. 
Microscopic techniques Qualitative Scanning electron microscopy (SEM) gives high-
magnication images of how the single bacteria are located 
and interact within the biolm. The initial attachment and 
dispersion of bacteria on the mineral surfaces. Transmission 
electron microscopy (TEM), reveal greater detail precise 
location of the iron precipitation on cell surfaces. 
Confocal laser microscopy (CLSM) with restricted 
magnication, SEM requires dehydration of the 
samples during preparation. 
Air-liquid  interface 
coverslip assay 
Quantitative Straight forward approach for quantifying biofilms on biotic 
surfaces. It is a robust method and gives same results  
obtained with other biolm assays. 
It hampers progress of the experiment. 
Colony Biofilms Qualitative Analysis of bacteria in contact with antimicrobial agents.  Live, non-destructive image of biofilm development 
cannot be carried out. 
Congo red agar method 
(CRA) 
Qualitative Rapid, sensitive, reproducible. The colonies remain viable 
on the medium.  
Non reliable method, possibility of false positive 
results. 
Safranine  (SAF) Quantitative It detects both live and dead bacteria, and the biofilm ma-
trix. 
Time sensitive, Aspects related with cell viability 
during different stages of the biofilm formation 
cannot be studied. 
 Borosilicate test tubes 
(TT) 
Qualitative This test correlates well with TCP test but cannot discrimi-
nate biofilm formation capacity.  
Possibility of false positive and cannot be recom-
mended as general screening test for identification of 
biofilm-producers. 
Rresazurin (RES) Quantitative Determination of viable cells depending on the reduction of 
the non fluorescent RES to the fluorescent resorufin. This 
proportionally reflects the amount of metabolically active 
cells. 
Time sensitive, Aspects related with cell viability 
during different stages of the biofilm formation 
cannot be studied. 
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Table 2. Summary for the few contributions along with biofilm formation using Microtiter plate static biolm model. 
Organism Work Contributed Towards References 
Salmonella typhimurium Determination of antibiotic resistance pattern and biofilm formation. [115] 
Staphylococcus aureus, Staphylococcus  
epidermidis 
Development of new antimicrobial agents against multidrug-resistant infections and 
biofilm-associated diseases. 
[116] 
C. krusei, C. guilliermondii First time a comprehensive study regarding adhesion to polystyrene was performed 
which is significant for species virulence attributes. 
[117] 
Enterococcus faecalis,  
E. faecium 
Investigations for possible associations between virulence profiles and biofilm forma-
tion in clinical urinary tract infection (UTI) isolates. 
[118] 
 
 Staphylococcus aureus 
 To test the efficacy of octenidine hydrochloride (OH) to inhibit biofilm synthesis and 
inactivation of fully-formed staphylococcal biofilm on different matrices with and 
without serum protein. 
[119] 
Enterobacter cloacae For determination of the effects of growth medium, temperature, and incubation time 
on biofilm formation. 
[120] 
Candida albicans Monitoring Formation and Antifungal Susceptibility Testing. [121] 
Candida albicans, C. parapsilosis, and C.  
glabrata 
For enhancement of the detection of drug susceptibility differences among strains. To 
make it possible for high-throughput screening of antifungal compounds.  
[122] 
Acinetobacter baumanni 
(ATCC 19606), Pseudomonas aeruginosa 
(ATCC 27853)  
To determine the probable relationship between colonization of different medical 
devices by various bacteria and the differences in biofilm formation under different 
conditions.  
[123] 
Pseudomonas aeruginosa Formation of biofilm formation.  [113] 
Pseudomonas aeruginosa  To test the antimicrobial susceptibility testing. [124] 
Staphylococcus epidermidis 
 
Biofilm production in 96-well plates is affected to low oxygen content and should be 
considered in the interpretation of experimental work using this biofilm model. 
[125] 
Rhodococcus erythropolis  First report on use of Microtitre assay for the production and utilization of Hydroxy-
biphenyl. 
[126] 
Escherichia coli The attachment promotion and disruption by indolic compounds. [127, 128] 
Staphylococcus aureus Identification of mutants deficient in surface attachment. [129] 
Staphylococcus aureus Effects of surface properties on bacterial attachment to the surfaces. [130] 
Staphylococcus epidermidis The attachment promotion and disruption by indolic compounds for and evaluating 
the role of salt and ethanol stress on biofilm formation. 
[131] 
Bacillus subtilis Identification of mutants deficient in surface attachment. [132] 
Vibrio cholerae Identification of mutants deficient in surface attachment. [133] 
Pseudomonas  fluorescens Effect of nutrients in the medium on attachment to polyvinyl chloride. [134] 
Pseudomonas  fluorescens,  
 Pseudomonas  aeruginosa 
Identification of genetic requirements involved in surface attachment.   [134, 135] 
 
summary 2 ml of trypticase soy broth (TSB; Difco Laboratories, 
Detroit, MI, USA) in 12 x 75 mm borosilicate test tubes (Corning, 
Tewksbury, MA, USA) were inoculated with a loopful of microor-
ganisms from overnight culture plates and incubated for 48 hours at 
37°C, after which the contents were decanted and washed with PBS 
(pH 7.3) and left to dry at room temperature. Afterward, the tubes 
were stained with 4% solution of crystal violet (Merck, Darmstadt, 
Germany). Each tube was then gently rotated to ensure uniform 
staining and then the contents were gently decanted. The tubes were 
placed upside down to drain and then observed for biofilm forma-
tion which was considered positive when a visible film lined the 
wall and bottom of the tubes. Ring formation at the liquid interface 
was not regarded as indicative of biofilm formation. The results 
were scored visually as 0-absent, 1-weak, 2-moderate, 3-strong. 
4.3. Congo Red Assay (CRA) Method 
 This technique is mainly based on the morphological cultural 
characteristic of biofilm-forming bacteria on medium supplemented 
with Congo red. The medium preparation is brain heart infusion 
broth (BHI) containing 37 g/l, sucrose 50 g/l, agar 10 g/l and Congo 
red 0.8 g/l. Medium is sterilized (121°C for 15 minutes) after add-
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ing all the components without Congo red stain (used as a strong 
aqueous solution) which was separated from the rest of the medium 
components and supplemented to the agar when the temperature 
reached 55°C. After preparation of agar plates, they are inoculated 
and incubated for 24 hrs at 37°C. Results are interpreted based on 
the biofilm producers giving black colour colonies with a dry crys-
talline consistency where red colour colonies developed as the or-
ganisms was taken to indicate biofilm production whereas non-
biofilm-producing strains develop red colonies [136]. There is an 
interaction between Congo red dye and certain polysaccharides that 
can form colored complexes which is helpful for phenotypic char-
acterization of biofilm production. Freeman et al. [137] proposed 
that biofilm producers form black colonies on Congo red agar 
plates, whereas non-producers form red colonies. The Congo red 
dye directly interacts with certain polysaccharides, forming colored 
complexes [138]. A five-color reference scale can be used to deter-
mine color variations by the colonies accurately. Those isolates 
showing two tones like black, bright black (BB) and dry-opaque 
black (OB), are classified as biofilm producers. The others showing 
red, pink and bordeaux colonies are classified as negative one. In 
few cases, the colour variations are also seen like red and bordeaux 
subcolonies in the center of black colonies (BB) after 48 h of cul-
ture. These colonies are removed and can be subcultured for isola-
tion of the producing and non-producing variants.  
4.4. Flow Cell System 
 This system has a chamber where biofilm forming bacteria are 
grown and are usually attached to a cover slip overlying the cham-
ber. Some of the important specifications need to be followed while 
working with this system for growth of biofilms  are collection of 
fresh, optimized biomass, tube biofilms and spin-disc reactors. The 
main advantage of working with this system is biofilms can be 
visualized at real-time. Small continuous-flow systems is provided 
with a viewing port that permits direct observation of the biofilm 
without any troublesome to the community. Fresh medium is en-
tered in the system, passed through the cell, and waste is collected. 
There are no provision that medium is not recycled through the 
flow cell. A number of descriptions of flow cell and related tech-
niques have been reported. However, these experiments are not 
suitable for high-throughput analysis. Pamp and Tim Tolker-
Nielsen, [109] used flow cell technology and enhanced confocal 
laser scanning microscopy and suggested that the BSs produced by 
P. aeruginosa play supplementary roles in development of biofilm. 
The authors have presented genetic evidence for endorsing the mi-
crocolony formation in the initial phase. The later phase, migration-
dependent structural development is also resulted in this complex 
reaction cycle.  The rhlA mutants of P. aeruginosa deficient in syn-
thesis of BSs, cannot accomplish the task of microcolonies forma-
tion in the initial phase. Authors proved the concepts by using two 
and three color-coded mixed-strains of P. aeruginosa for the ex-
perimental work.   
4.5. Tube Biolm Reactors  
 This system works similar to flow cells reactor where biofilms 
that are build up under flow can be investigated. The distinction 
between these two methodologies is that in the tube reactor where 
biofilms are grown on the interior surface of silicone tubing, instead 
of on a cover slip attached to a chamber.  Huge growth of biofilms 
can be observed on the tube biofilm that can enables the accumula-
tion of a large biofilm mass which can be collected effortlessly by 
just scraping from the tubing. An important prospective of this sys-
tem is allowing estimation of the effect of antibacterial agents on 
biofilms through counting of colony forming units. This purpose 
can be achieved by analysis before and after exposure to treatment 
with the tested agent. In addition to these, biofilm mass can be stud-
ied for biochemical and gene expression purposes. Another most 
important aspect that is phenotypic diversification also can be ana-
lyzed [139].  
4.6. Rotating Disk Reactors (RDR) 
 In this system biofilms are grown under shear stress and can be 
examined for the efficacy of biocide. The RDR system consists of a 
circular disk which is made in such a way that it permits the inte-
gration of removable coupons or chips which can be flushed with 
surface of the disk. Zelver et al. [140]; Ramey and Parsek, [141] 
suggested that the disks can be made from a variety of materials 
depending upon the subject of matter under studies. There is a star-
head magnet where the disk is attached and this is placed in a 1 L 
glass side-arm reactor vessel. This reactor vessel is placed on the 
top of magnetic stirrer where adjustable rotational speed is provided 
through the generation of a liquid shear force across the surface of 
the disk. Different shear strength can be produced through the speed 
of rotation and as well as the diameter of the cylinders. Another one 
important feature of this system is maintaining the flow of medium 
through the reactor regulated by pump. Reservoir system is avail-
able from where medium is pumped out and dripped down slowly 
into the reactor vessel. It is very much possible to remove coupons 
from the RDR so that growth or viability can be monitored asepti-
cally and bacteria can be plated for relative viable cell counts at 
various intervals of growth. Therapeutic efficacy evaluation can be 
accomplished with bioactive molecules / chemicals by introducing 
them in the reaction vessel or distributing by the continuous flow in 
the medium.  
4.7. Concentric Cylinder Reactors (CCR) 
 This system is provided with two concentric cylinders. Sample 
under test is applied on the removable slides which are attached 
with the internal walls of the outer static cylinder. Medium is fed 
through the inter cylinder space and then inner cylinder starts rotat-
ing. After inoculation, biofilms starts developing on the walls of the 
cylinder [142]. This methodology assists the role of hydrodynamic 
conditions on biolms and different shear stress conditions can be 
observed. At the same time is also allows to test different shear and 
periodical sampling can be easily carried out. The problem working 
with this system is that only per experiment only one surface mate-
rial is tested. Another issue is that the system is non availability of 
enough sampling surface area and difficulty in sampling process. 
4.8. Microscopic Techniques  
 Due to the rich emergence of several techniques like phase 
contrast microscopy (PCM), fluorescence imaging microscopy 
(FIM), scanning electron microscopy (SEM), transmission electron 
microscopy (TEM), confocal laser microscopy (CLSM), atomic 
force microscope (AFM) reasonably superior level of biofilms have 
been explored the microscopic world. High quality resolution of 
microscopic biofilms has been achieved and advancement towards 
in these areas is also opening wide gates to understand biofilms 
thoroughly. Image analysis of Cellular and sub-cellular components 
had always tried to answer my biological queries. Initially, electron 
microscopy was the choice to observe microbial biofilms under 
high resolution. Three-dimensional structure of biofilms has been 
successively revealed by several researchers. Few researchers [143-
145], demonstrated microscopic biolm formation. The method can 
be performed by slight variation in the assay described by Jeong 
and Frank, [143] and Blackman and Frank, [144]. The experimental 
set up use stainless steel surfaces and PVC.  Both materials need 
proper cleaning treatments. Stainless still surfaces are cleaned and 
placed in 12- by 1.5-cm tubes for sterilization by autoclaving. Ster-
ilized tube with broth (10 ml to immerse completely both surfaces) 
and inoculated with culture. Further slides are removed from the 
growth medium and washed with distilled water to remove any 
loosely attached cells, and are xed with 95% ethanol for 45 s. 
Djordjevic et al. [145] used to assay for formation and analysis of 
biofilm from Listeria monocytogenes. Then biofilm formation can 
be observed under the microscope. 
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4.9. Colony Biofilms  
 Generally a colony of biofilm is developed on a semi-
permeable polycarbonate filter (GE) which is placed on a suitable 
medium. Here filter is provided as a surface so that transfer of the 
surface-grown biofilm is expedient from one medium source to 
another one. It is possible to observe the growth of biofilm forma-
tion at the air–surface interface. In this case there is no absolute 
necessity of submersing the biofilm in liquid medium. Within short 
time span, depending upon the kind of growth, biofilm can form 
huge colonization. Experimental work demonstrated by Borriello et 
al.  [146], Werner, et al. [147]; Stewart et al. [148] showed that 
after 48 h of growth colony biofilm formed by P. aeruginosa, is 
approximately 150–300 m thick whereas S. epidermidis produces 
about 100 m thick. It is important to note that colony biofilms 
exhibit a typical stratified profile comparable to flow cell biofilms 
at an anaerobic conditions. The interior colony biofilm is dominated 
by lysed cells and at the colony–air interface where more oxygen is 
available, the exponential phase cells are found [147]. 
5. INDUSTRIAL PROSPECTUS OF BIOSURFACTANT 
MOLECULES IN BIOFILM DISRUPTION:  
 Bio-medical device always need always be free from organ-
isms. Many different cleaning compounds available today in the 
market may not necessarily be effective as biolm disruptors [149]. 
It is very important to note the comment given by Fracchia et al. 
[150] excessive disinfection treatment may yield less efficiency. 
Most of the devices which are used in hospitals are disposable, i.e. 
there are no issues of development of biofilms on those devices. In 
case of some reusable medical devices like surgical instruments, 
endoscopes, biofilms have no possibility to develop when the de-
vices are sterilized / disinfected after their usage. One of the possi-
ble opportunities to develop biofilms is though longer contact of 
organisms on the medical device which can get attached irreversi-
bly [151]. There is mounting interest in the potential of BS mole-
cule in medically-related applications including the formation and 
disruption of bacterial biolm [9-11]. Some antibiofilm activity of 
BS produced by different microorganisms against pathogenic mi-
croorganisms is given in the summary of Table 3. 
 Among all reported BS, rhanmonolipid types BS have shown 
great potential applications. RHLs are reported involved in main-
taining the structural characteristics of biolm and have accepted 
useful application to prevent biofilm formation on surfaces of vari-
ous biomedical devices [157]. Other issue like diffusion of nutrients 
and gases to the cells within the biolm needs to be considered. 
Like RHLs, sophorolipid type glycolipids also wok as biofilm dis-
ruptors at different concentrations. Studies conducted by D´	az et 
al. [23] showed the inhibition of Cupriavidus necator ATCC 
17699, Gram positive B. subtilis BBK006 by sophorolipids (con-
centrations of 5% v/v) possessing bactericidal effect. At the same 
concentration single or mixture of colonies are also disrupted. The 
authors suggested the use of SPs as adjuvants to other antimicrobial 
against for disruption of biofilm. Two well know BS, viz., surfactin 
(B. subtilis) and RHLs (P. aeruginosa) lowers the adhesion and 
disrupts biolms of food-borne pathogenic bacteria [165]. Their 
studies included S. aureus, Listeria monocytogenes and Salmonella 
Enteritidis on polystyrene surface.  Both BS works effectively in 
controlling the attachment as well as disruption of individual and 
mixed culture biofilms of the food-borne pathogens. Biofilms 
formed by candida spp. are one of the most dangerous one. Gomes 
et al. [165] examined the effect of BS isolated from Pseudomonas 
aeruginosa DSVP20 for disruption of C. albicans biofilm.  Time to 
time we have seen that microscopic analyses by using SEM and 
CLSM gives a very clear cut visualization of disruptive effect of BS 
on biofilms thus proved to be effectiveness of BS for therapeutic 
purposes. Some of the commercial BS based formulations that are 
used to inhibit biofilm disruption are listed in the Table 4. 
 
Table 3. Antibiofilm activity of biosurfactant produced by different microorganisms against pathogenic microorganisms. 
Name of the Organism Producing 
Biosurfactant 
Name / Type of Biosur-
factant Produces 
Antibiofilm Activity Against References 
Lactobacillus brevis CV8LAC Not mentioned  Initial deposition of Candida albicans on medical devices [152] 
Pseudomonas aeruginosa MA01 Rhamnolipid  S. aureus, B. subtilis, P. aeruginosa, K. pneumoniae [153] 
Candida bombicola ATCC 22214 Sophorolipids  Staphylococcus aureus ATCC 9144, Cupriavidus necator ATCC 
17699 and Bacillus subtilis 
[23] 
Lactobacillus jensenii Lactobacillus 
rhamnosus 
Not mentioned Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus [58] 
Coral Associated Bacteria (CAB)  Lipopeptide Pseudomonas aeruginosa ATCC10145 [154] 
Lysinibacillus fusiformis 
S9. 
Glycolipid Escherichia coli and Streptococcus mutans [62] 
Bacillus sp. strain SW9 Lipopeptide Different strains of bacteria [155] 
Bacillus tequilensis Lipopeptide Escherichia coli, Streptococcus mutans [156] 
Robinia pseudocacis/  
Nerium oleander 
Not mentioned Candida albicans [157] 
Pseudomonas aeruginosa Glycolipid Yarrowia sp. [50] 
Candida lypolytica Rufisan Streptococcus sp.  [158] 
Serratia marcescens Glycolipid Candida albicans and Pseudomonas aeruginosa and the marine 
biofouling bacterium Bacillus pumilus 
[65] 
Candida sphaerica Mixed BS- Lunasan Pseudomonas aeruginosa, S.agalactae [159] 
Bacillus strain Lipopeptide Different Gram positive and negative bacteria [160] 
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Name of the Organism Producing 
Biosurfactant 
Name / Type of Biosurfac-
tant Produces 
Antibiofilm Activity Against References 
Actinobacterium Brevibacterium 
casei MSA19 
Glycolipid      Candida albicans FC1, Escherichia coli MTCC 2939, Proteus 
mirabilis PC1, Hemolytic Streptococcus PC2, Pseudomonas aeru-
ginosa MTCC 2453, Klebsiella pneumoniae PC3, Vibrio para-
haemolyticus MTCC 451, Vibrio harveyi MTCC 3438, Vibrio 
alginolyticus MTCC 4439, Vibrio alcaligenes MTCC 4442, Vibrio 
vulnicus MTCC 1145, Thalassomona ssp. MMD12, Alteromonas 
sp. MMD16, Pseudoalteromonas sp. MMD18, Pseudoaltero-
monas sp. MMD19, Ruegeria sp. MMD27  
[64] 
Pseudomonas aeruginosa Glycolipid Bacillus pumilus [161] 
Lactobacillus paracasei A20 Not mentioned Different strains of bacteria, yeast, filamentous fungi [162] 
Arctic bacterium Pseudomonas fluo-
rescens BD5 
Lipopeptide Pseudofactin II Escherichia coli, Enterococcus faecalis, Proteus mirabilis, can-
dida spp. 
[163] 
Bacillus subtilis,  
B. licheniformis 
Lipopeptide-Fengycin Escherichia coli, S. entrica [164] 
Pseudomonas 
aeruginosa DS10-129 
Rhamnolipid  Staphylococcus epidermidis GB 9/6, Strep. salivarius GB 24/9, 
Staphylococcus aureus GB 2/1 and C. tropicalis GB 9/9 
[9] 
Pseudomonas putida strain PCL1445 Lipopeptide putisolvin I & 
II 
Different Pseudomonas strains  [48] 
Lactococcus lactis / Streptococcus 
thermophilus 
Mixed BS- Lunasan Staphylococcus, Streptococcus, Rothia, Candida sp. [60] 
Bacillus subtilis Lipopeptide S. entrica [47] 
Lactobacillus fermentum B54 Lipopeptide Urophathogens [57] 
L. acidophilus RC14 
and L. fermentum B54  
L. casei subsp. rhamnosus 36 & 
ATCC 7469 
Protein rich BS, High poly-
saccharide and phosphate 
contents. 
Uropathogenic Enterococcus faecalis [54] 
 
Table 4. Commercial available biosurfactant based formulation to inhibit biofilm disruption. 
Source Organism Commercial Available Biosurfactant Industrial Prospectus as Biofilm Disruption Against References 
Lipopeptide based biosurfactants 
Polymyxin Pseudonomas aeruginosa [166] 
Lipopeptide – Polymyxins 
Colistin (Polymyxins E) 
Gram negative bacteria [167] 
Neosporin, Polymyxin B  
(Supplied as polymyxin B sulphate)  
Polymyxin + Trimethoprim neomycin + 
Bacitracin  
(Triple antibiotic ointment  
Wide range of bacterial population [79] 
 
 
 
 
 
 
 
Bacillus spp. 
Polymyxin D1 
Polymyxin D1 + Fusaricidin  + Surfactin  
Mixed biofilm population [168] 
 
 
Multiple Roles of Biosurfactants in Biofilms Current Pharmaceutical Design, 2016, Vol. 22, No. 11    1443 
(Table 4) Contd…. 
 
Source Organism Commercial Available Biosurfactant Industrial Prospectus as Biofilm Disruption Against References 
Fengycin type biosurfactants 
Pseudomonas putida Cyclic lipopeptide 
 Putisolvin I & Putisolvin II 
Dispersal agent- against other Pseudomonas strains [48] 
Fengycin like Lipopeptide Gram positive bacteria - S. aureus  [169] Bacillus subtilis & B. 
licheniformis 
Fengycin like Lipopeptide Gram negative bacteria - E. coli [14] 
Pseudofactin type biosurfactants 
Pseudomonas fluores-
cens 
Cyclic lipodepsipeptide 
Pseudofactin 
E. coli,  S. epidermidis, E. faecalis, E. hirae, Proteus 
mirabilis 
[163] 
Surfactin type biosurfactants 
Bacillus subtilis Surfactin Salmonella spp. [47] 
Bacillus cereus Lipopeptide complexes Disruption of biofilm [156] 
Surfactant complex 
Bacillus licheniformis Lipopeptides  
(In combination with other disruptors/inhibitors) 
Uropathogen E. coli [164] 
Paenibacillus polymyxa Polymyxin D1+ Fusaricidin  B + Surfactin Disruption of biofilm -  E. coli, S. aureus [168-170] 
Glycolipid type biosurfactants 
Pseudomonas aerugi-
nosa 
Rhamnolipid Bordetella bronchiseptica [171] 
Pseudomonas aerugi-
nosa 
Rhanmonolipid biofungicin 
(Product developed by Jeneil Biosurfactant cor-
poration) 
Prevent crop attack by pathogenic fungi [172] 
Sophorolipid type biosurfactants 
Candida sphaerica Lunasan Pseudonomas aeruginosa, Streptococcus sanguis,  
S. agalacitae,  
[159] 
Candida lypolytica Rufisan S. aureus , Streptococcus sanguis, S. mutans [158] 
Candida spp. Sophorolipid E. coli [173] 
Candida bombicola Sophorolipid Vibrio cholerae [174] 
 
6. FUTURE PROSPECTUS  
 Broad views on research areas including food, water and envi-
ronment, clinical, pharmaceutical microbiology are assisting to 
explore more on biofilm perceptions. Knowledge on expression of 
particular genes in organisms associated with biofilm formation is 
also playing a supporting role to remediate biofilm colonization of 
several biomedical devices. One of the smart ways to handle the 
biofilm issues are exploring solutions to the emergence of resis-
tance of biofilm towards antimicrobial compounds and in develop-
ment of chronic diseases.  Industries need to lift these approaches in 
order to develop newer paths to prevent formation and control of 
biofilms. Noteworthy accomplishments can be achieved by acquir-
ing more comprehensive knowledge on how biofilm phenotypes are 
different from the planktonic phenotype. Wide ranges of multi-
resistant bacteria genera or fungi have been found to be inhibited 
through promising activity of BS molecules. Therefore, opportuni-
ties are offered by BS based pharmaceutical formulations for sub-
stantiate future medicine. Till today, lipopeptide and glycolipid 
based BS has shown exciting applications in large scale commercial 
grade products. Some of the newly reported BS like Lunasan, 
Rufisan can accelerate the development of new formulations to 
fulfill the specific requirement for the development of effective 
formulations. We need to explore more innovative BS molecules 
for antibiofilm activity and can be tried out for synergistic activity 
with other antibiofilm agents for preparation of different but effec-
tive combinations.   
CONCLUSION  
 Due to public health related issues the terms biofilms, BS, an-
timicrobial agents, antibiotic resistance are very significant. As 
prevention is always better than cure, we need to look for effective 
molecules to tackle the issue of biofilms caused by pathogens. More 
effective strategies for controlling biofilms formation and effective 
treatment would unquestionably offer us healthier environment and 
may positively contribute towards the reduction of antimicrobial 
resistance development through acting as adjuvants to may antibiot-
ics reducing their effective doses and accelerating microbial elimi-
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nation. Different methodologies involved in the cultivation of mi-
croorganisms would assist the researchers to choose suitable 
method required for intended purpose. High through put analyses 
can be achieved through microtitre and peg biofilm techniques. The 
flow cell device is very much helpful to observe biofilm formation 
microscopically. High possibility is expected to recover the biofilm 
for downstream biochemical analyses from the tube biofilm tech-
nique. We can assess the biofilm susceptibility to antimicrobials 
with peg biofilms, colony biofilms and the rotating disk, and con-
centric cylinder reactors. The current research is being focused on 
preventing the surface colonization rather than overall bacterial 
robustness. Development of more effective antibiofilm agents 
sounds to be more promising technology.  
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